Skip to main content

Table 1

From: Evolution of resistance in Acinetobacter baumannii in a Tunisian intensive care unit after antibiotherapy restriction

% of resistance 2001 (n = 134) 2003 (n = 50) P 2004 (n = 63) P'
Ticarcilline 76 63 0.05* 77 0.8
Piperacilline 97 85 0.01* 81 10-3*
Ceftazidim 95 84 0.01* 79 8 × 10-4*
Carbapenem 37 37 0.36 25 0.09
Amikacine 85 70 0.28 68 6 × 10-3*
Netilmycine 30 31 0.86 31 0.7
Ofloxacine 95 87 0.04* 93 0.9
Ciprofloxacine 95 87 0.16 94 0.9
  1. P, 2003 – 2001; P', 2004 – 2001. *P < 0.05.